Christopher K. Scott net worth and biography

Christopher Scott Biography and Net Worth

CFO of Iradimed

Mr. Scott has served as our Chief Financial Officer and Corporate Secretary since December 2013. Mr. Scott has extensive experience in finance and accounting. Mr. Scott held a management position at Darden Restaurants, Inc. from 2010 to 2013, where he provided accounting and reporting oversight.

From 2002 to 2010, Mr. Scott served as an auditor and senior manager at KPMG LLP. Mr. Scott received a B.S. in Accounting from the University of Central Florida in 2002.

What is Christopher K. Scott's net worth?: The estimated net worth of Christopher K. Scott is at least $1.77 million as of August 6th, 2018. Mr. Scott owns 32,398 shares of Iradimed stock worth more than $1,770,551 as of December 21st. This net worth estimate does not reflect any other assets that Mr. Scott may own. Learn More about Christopher K. Scott's net worth.
How do I contact Christopher K. Scott?: The corporate mailing address for Mr. Scott and other Iradimed executives is 1025 Willa Springs Dr., Winter Springs FL, 32708. Iradimed can also be reached via phone at (407) 677-8022 and via email at [email protected]. Learn More on Christopher K. Scott's contact information.
Has Christopher K. Scott been buying or selling shares of Iradimed?: Christopher K. Scott has not been actively trading shares of Iradimed over the course of the past ninety days. Most recently, Christopher K. Scott sold 19,286 shares of the business's stock in a transaction on Friday, February 11th. The shares were sold at an average price of $50.06, for a transaction totalling $965,457.16. Learn More on Christopher K. Scott's trading history.
Who are Iradimed's active insiders?: Iradimed's insider roster includes Monty Allen (Director), James Hawkins (Director), Brent Johnson (VP), Christopher Scott (CFO), Roger Susi (CEO), and Anthony Vuoto (Director). Learn More on Iradimed's active insiders.
Are insiders buying or selling shares of Iradimed?: During the last year, insiders at the medical equipment provider sold shares 2 times. They sold a total of 7,500 shares worth more than $365,450.00. The most recent insider tranaction occured on December, 2nd when CFO John Glenn sold 2,500 shares worth more than $135,450.00. Insiders at Iradimed own 37.1% of the company. Learn More about insider trades at Iradimed.
Information on this page was last updated on 12/2/2024.

Christopher K. Scott Insider Trading History at Iradimed

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/11/2022	Sell	19,286	$50.06	$965,457.16
11/23/2021	Sell	26,715	$40.98	$1,094,780.70
8/8/2018	Sell	96,250	$26.05	$2,507,312.50	32,398
8/6/2018	Sell	26,297	$26.16	$687,929.52	32,398

Christopher K. Scott Buying and Selling Activity at Iradimed

Iradimed Company Overview

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Today's Range

Now: $54.65

$52.90

$55.15

50 Day Range

MA: $52.97

$48.30

$57.35

2 Week Range

Now: $54.65

$40.18

$57.95

Volume

90,292 shs

Average Volume

48,832 shs

Market Capitalization

$692.58 million

P/E Ratio

37.43

Dividend Yield

1.13%

Beta

0.82

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.